CVE-2024-2274
Published: 08 March 2024
Summary
CVE-2024-2274 is a low-severity Cross-site Scripting (CWE-79) vulnerability in Bdtask G-Prescription Gynaecology \& Obs Consultation. Its CVSS base score is 2.4 (Low).
Operationally, ranked at the 32.1th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-27229
Vulnerability details
A vulnerability, which was classified as problematic, has been found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. This issue affects some unknown processing of the file /Home/Index of the component Prescription Dashboard. The manipulation of the argument Title…
more
leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The associated identifier of this vulnerability is VDB-256043. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.